SMAD2 and coronary artery disorder: Among the 12 novel genes, RBFOX2, SMAD2, CDK13 are three emerging CHD risk genes that have been recently reported to cause hypoplastic left heart syndrome [4,45,46], laterality defect [3,47], and septal defects and pulmonary valve abnormalities [48], respectively.